Cationic Polypeptides Are Required for Antibacterial Activity of Human Airway Fluid

  • Cole A
  • Liao H
  • Stuchlik O
  • et al.
181Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In a search for direct evidence leading to the biological relevance of airway secretions in innate host defense, we characterized the antibacterial function of cationic polypeptides within minimally manipulated nasal fluid. In this study, we show that cationic antimicrobial polypeptides are responsible for most of the bactericidal activity of whole nasal fluid. The removal of cationic polypeptides using a cation-exchange resin ablated the activity of nasal fluid against Escherichia coli, Listeria monocytogenes, and Pseudomonas aeruginosa. By using a novel proteomic approach, we identified a dozen cationic peptides and proteins within nasal fluid, all of which either are known antimicrobial polypeptides or have other proposed roles in host defense. Of the three most abundant cationic polypeptides in nasal fluid, lysozyme was more effective than either lactoferrin or secretory leukoprotease inhibitor in restoring the antibacterial activity of the cationic polypeptide-depleted fluid against a mucoid cystic fibrosis isolate of P. aeruginosa.

Cite

CITATION STYLE

APA

Cole, A. M., Liao, H.-I., Stuchlik, O., Tilan, J., Pohl, J., & Ganz, T. (2002). Cationic Polypeptides Are Required for Antibacterial Activity of Human Airway Fluid. The Journal of Immunology, 169(12), 6985–6991. https://doi.org/10.4049/jimmunol.169.12.6985

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free